X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
activated protein-kinase (1) 1
antibodies, monoclonal - therapeutic use (1) 1
anticancer properties (1) 1
antineoplastic agents - therapeutic use (1) 1
antitumor agents (1) 1
article (1) 1
b-lymphocytes - metabolism (1) 1
braf inhibitor resistance (1) 1
cd20 antigen (1) 1
cell survival (1) 1
cisplatin - therapeutic use (1) 1
drug resistance (1) 1
drug resistance, neoplasm (1) 1
emergence (1) 1
establishment (1) 1
fibroblast growth factor (1) 1
fibroblast growth factor 2 (1) 1
fibroblast growth factor 2 - metabolism (1) 1
fibroblast growth factor receptors (1) 1
growth (1) 1
growth factors (1) 1
humans (1) 1
in vitro techniques (1) 1
index medicus (1) 1
inhibitors (1) 1
insulin-like growth factor i (1) 1
insulin-like growth factor i - metabolism (1) 1
insulin-like growth factors (1) 1
lymphocytes (1) 1
lymphocytes b (1) 1
lymphocytes, tumor-infiltrating - metabolism (1) 1
mek inhibitors (1) 1
melanoma (1) 1
melanoma - drug therapy (1) 1
melanoma - genetics (1) 1
metastases (1) 1
metastasis (1) 1
multidisciplinary sciences (1) 1
paclitaxel - therapeutic use (1) 1
patients (1) 1
phenotype (1) 1
pilot projects (1) 1
prognosis (1) 1
protein kinase inhibitors - therapeutic use (1) 1
proto-oncogene proteins b-raf - genetics (1) 1
receptor, fibroblast growth factor, type 3 - metabolism (1) 1
science (1) 1
skin neoplasms - drug therapy (1) 1
skin neoplasms - genetics (1) 1
subpopulations (1) 1
suppression (1) 1
therapy (1) 1
transcription (1) 1
tumor microenvironment (1) 1
tumors (1) 1
vaccines (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 1 - 16
Journal Article
Nature communications, 09/2017, Volume 8, Issue 1, p. 607
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.